PF4 and Thrombocytopenia: Indeed, the European Medicines Agency (EMA) had to revise its initial statement denying any relationship between vaccination and thrombotic events after Greinacher et al. identified a small number of atypical cases characterized by unusual sites of thrombosis, thrombocytopenia, and circulating anti-PF4 antibodies (3, 4).